Skip to main content

New Products

  • Real Health Labs launches Prostate Complete Once Per Day

    SAN DIEGO — Real Health Labs recently launched Prostate Complete Once Per Day, a pharmaceutical-grade supplement combination, the company stated. 

    In addition to zinc, selenium and vitamin E, Prostate Complete Once Per Day is formulated with a standardized saw palmetto extract, lycopene, a standardized curcumin extract, resveratrol and a pomegranate concentrate. 

  • Alere Wellbeing publishes book touting Quit For Life smoking-cessation program

    SEATTLE — After years of successfully helping tobacco users quit with the Quit For Life Program, Alere Wellbeing has launched a new book designed to bring that expertise to the everyday consumer. Anyone wanting to quit tobacco can now purchase a copy of Quit Smoking for Life, written by health writer Suzanne Schlosberg with the help of Quit Coaches from the program.

  • FDA approves generic hypertension pill made by Actavis

    DUBLIN — The Food and Drug Administration has approved a generic drug for high blood pressure made by Actavis, the company said Friday.

    Actavis announced the approval of telmisartan immediate-release tablets in the 20-mg, 40-mg and 80-mg strengths, which it intends to release immediately.

  • Lindt announces new premium chocolates

    STRATHAM, N.H. — Lindt and Sprungli has introduced a bevy of new premium chocolate offerings, with flavor combinations ranging from sweet-and-salty to milk chocolate. 

    The new product offerings include Lindor Coconut truffles, Classic Recipe Caramel with Sea Salt bars, special additions to the Lindt Chocolate Specialties line, and the first-ever Lindt Brownie Mixes.

  • FDA approves combination of two GSK drugs for skin cancer

    SILVER SPRING, Md. — The Food and Drug Administration has approved two drugs made by GlaxoSmithKline for use together in patients with advanced melanoma that can't be removed by surgery or has spread to other parts of the body, the agency said Friday.

    The FDA announced the new approval for Mekinist (trametinib) and Tafinlar (dabrafenib). The agency originally approved the two drugs for use as single agents for the same indication in May 2013.

  • FDA approves liquid form of Merck HIV drug Isentress for infants, small children

    WHITEHOUSE STATION, N.J. — The Food and Drug Administraiton has approved a liquid formulation of an HIV drug made by Merck, the company said.

    Merck announced the approval of Isentress (raltegravir) for oral suspension, aimed at small children with HIV. The drug may be used by patients as young as four weeks, and the full line of formulations of Isentress now includes the orlal suspension, as well as chewable tablets and film--coated tablets. The company plans to launch the oral suspension in the third quarter of this year.

  • Maloof Ventures launches Never Hungover

    LOS ANGELES — Maloof Ventures announced on Friday the launch of Never Hungover at GNC. Never Hungover is a dietary supplement that is comprised of a natural vitamin blend, antioxidants, amino acids, nutrients and minerals packaged as a 2-oz. serving. 

    The hangover shot is designed to take up to an hour before or while consuming alcohol, and experiences optimal results when taking one bottle per four drinks. 

  • The new general market

    NEW YORK — Natural skin care company Sundial Brands is taking a re-imagined approach to the shopper population. Enter the new general market.

    The notion is that future success will be governed by consumer lifestyle insights and not ethnicities alone.

    Those retailers who tap into lifestyle trends stand to benefit and the brand is positioning itself to help.

X
This ad will auto-close in 10 seconds